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TO THE EDITOR
The hair follicle (HF) is a skin appen-
dage that shows cyclic activity with
periods of growth and hair fiber pro-
duction (anagen), apoptosis-driven in-
volution (catagen), and relative resting/
hair shedding (telogen/exogen) (Stenn
and Paus, 2001). Proliferation, differ-
entiation, and apoptosis in HF kerati-
nocytes are controlled by a number of
signaling molecules that belong to the
bone morphogenic protein/transform-
ing growth factor-b, epidermal growth
factor, fibroblast growth factor, Hedge-
hog, IGF, Notch, neurotrophin, tumor
necrosis factor, and Wnt families (Stenn
and Paus, 2001; Botchkarev and Kishi-
moto, 2003; Paus and Foitzik, 2004).
The decrease in proliferative activity or
activation of apoptosis in the matrix
region leads to hair growth retardation
and/or alterations in HF cyclic activity.
Therefore, molecules involved in the
control of cell proliferation and/or
apoptosis are of interest for hair growth
modulation (Cotsarelis and Millar,
2001).
Survivin is a member of the inhibitor
of apoptosis protein family, and has
been implicated in the control of cell
proliferation, as well as in the inhibition
of apoptosis (Ambrosini et al., 1998;
Wheatley and McNeish, 2005). Survi-
vin functions as a component of the
chromosomal passenger complex,
which is essential for cell division (Li
et al., 1999; Temme et al., 2003). In
addition, survivin inhibits apoptosis by
either directly or indirectly interfering
with the functions of caspases (Tamm
et al., 1998; Banks et al., 2000).
Transgenic mice expressing survivin
under control of the keratin 14 promo-
ter show significantly reduced number
of apoptotic cells in the epidermis after
UV exposure (Grossman et al.,
2001). In contrast, molecular survivin
antagonists increase the susceptibility
of numerous cell lines to apoptosis (Xia
et al., 2002; Kappler et al., 2004).
Survivin expression is elevated in ma-
jority of human cancers. It has potential
as a marker for diagnostics, as well as a
prognostic and therapeutic target for
radio- and chemotherapy (Altieri, 2003;
Rodel et al, 2005). The dual functions
of survivin in promoting cell prolifera-
tion and preventing apoptosis raises a
question about its involvement in reg-
ulating anagen and catagen phases of
the hair cycle, during which hair matrix
keratinocytes extensively proliferate
and undergo apoptosis (Stenn and Paus,
2001; Botchkareva et al., 2006).
To explore survivin expression in
human skin, survivin gene transcription
and survivin protein expression in the
epidermis and HFs was characterized
by real-time PCR analysis and immuno-
histochemistry, respectively (human
scalp skin was obtained from face-lifts
remains with written patient consent
from five different individuals; the study
was approved by an independent In-
stitutional Review Board to ensure
subject protection and adherence to
the Declaration of Helsinki Principles).
By real-time PCR analysis, survivin
mRNA expression was observed in
anagen HFs, as well as in the epidermis
(PCR primer set was obtained from
SuperArray Bioscience Corporation,
Frederick, MD). Relative quantification
revealed that levels of survivin mRNA
are substantially higher in the HF than
in the epidermis (Figure 1a).To deter-
mine localization of survivin in skin,
rabbit polyclonal antibody against hu-
man survivin protein (1:1,000; Chemi-
con International Inc., Temecula, CA)
was applied, using 8-mm frozen tissue
sections fixed in 10% formalin (10 min)
and post-fixed in ethanol-acetic acid
(5 min, 201C) and the tyramide-
amplification method, as described
before (Botchkareva et al., 2003). In
the epidermis, survivin was expressed
only in few basal cells (Figure 1b). In
the anagen HF, survivin was promi-
nently expressed in the hair matrix and
outer root sheath, and survivin coloca-
lized with proliferative marker Ki-67, as
determined by using rabbit monoclonal
antibody against Ki-67 (Dako, Carpin-
teria, CA) (Figure 1c and d). Double
immunostaining with antibody against
survivin and the marker of melanocytes
pMel-17 (using chicken anti-gp100/
pMel-17; Zymed Laboratories, San
Francisco, CA) revealed that none of
the cells expressing survivin either in
the outer root sheath or hair matrix
showed pMel-17 immunoreactivity in
anagen and early-catagen HFs, suggest-
ing that survivin expression is restricted
to hair matrix and outer root sheath
keratinocytes (Figure 1e and f).
In early-catagen HFs, survivin ex-
pression decreased in the hair matrix
and disappeared from the outer root
sheath (Figure 1g). During mid-catagen,
the number of survivin-positive cells
further decreased in the regressing hair
matrix (Figure 1h). Finally, in late
catagen, only a few surviving-positive
cells were detected in the regressing
epithelial portion of the HF (Figure 1i).
Because of the involvement of survivin
in inhibiting apoptosis, co-visualization
of survivin and apoptotic cells was also
performed using commercially avail-
able Apo-Direct TUNEL Assay kit (Che-
micon International Inc.). Lack of
colocalization of survivin and TUNEL
was detected in catagen HFs (Figure 1j).
Collectively, these data suggested that
survivin is involved in the maintenance
of HF growth by supporting proliferation
and protecting cells against apoptosis.
It was recently shown that transcrip-
tion of survivin is regulated by T-cell
factor (TCF)/b-catenin signaling: TCF-
binding sites were identified in the
promoter region of survivin, and the
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Abbreviation: HF, hair follicle
dominant-negative TCF isoform was
able to block survivin expression (Kim
et al., 2003). The Wnt/b-catenin path-
way plays key roles in HF growth
and differentiation (DasGupta and
Fuchs, 1999; Van Mater et al., 2003),
and we wished to clarify whether
interactions between survivin and
b-catenin are functional in the HF.
By double immunostaining with
antibodies against survivin and b-cate-
nin (1:50; R&D Systems Inc., Minnea-
polis, MN), we observed that some cells
expressing survivin in the hair matrix
are also b-catenin-positive (Figure
2a–c). These data suggested that the
expression of survivin in hair matrix
keratinocytes may be under the control
of and/or coordinated with Wnt/b-cate-
nin signaling.
To provide an experimental evi-
dence for crosstalk between survivin
and Wnt/b-catenin signaling in the HF,
ICG-001 (Institute for Chemical Geno-
mics, Seattle, WA), a small molecule
that inhibits survivin transcription via
blocking TCF/b-catenin binding to its
co-activator CREB-binding protein
(Emami et al., 2004; Ma et al., 2005),
was tested in HF organ culture model,
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Figure 1. Expression of survivin in human skin and HF. (a) Real-time relative PCR quantification revealed that survivin mRNA is expressed at higher levels in
anagen HFs than in the epidermis. (b) In the full thickness skin, only few cells in the basal layer of the epidermis are survivinþ (arrows). (c) In anagen HF,
survivin is detected in the hair matrix and outer root sheath (arrows and arrowheads, respectively). (d) Expression of survivin (Rhodamine) in Ki-67þ cells (FITC)
of the HF epithelium (arrows). (e, f) Double immunostaining of survivin (Rhodamine, arrowheads) and pMel-17 (FITC, arrows) revealed that the melanocytes do
not express survivin in anagen and early-catagen HFs. (g, h) Survivin expression disappears from the outer root sheath and progressively decreases in the hair
matrix during catagen development (arrows). (i) A few survivinþ cells are detected in the regressing epithelial strand during late catagen (arrows). (j) Lack of
survivin expression on TUNELþ cells (survivin shown in red, arrows; TUNEL shown in green, arrowhead).
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as described previously (Philpott et al.,
1994). ICG-001 was added to the
microdissected anagen HFs from occi-
pital human scalp skin derived from six
different female donors (aged 45–55
years). To determine survivin protein
content in the HFs treated with ICG-
001, a commercially available ELISA kit
was used (Assay Design Inc., Ann
Arbor, MI). By ELISA, a significant
decrease in the survivin protein levels
were observed in the HFs after 1 mM
ICG-001 treatment for 4 days, com-
pared to vehicle control (Po0.001;
Figure 2d). Concurrently, ICG-001 sig-
nificantly reduced hair fiber elongation
rate in a dose-dependent manner
(Po0.0001; Figure 2e). However,
ICG-001 did not cause premature cata-
gen development in cultured HFs. Hair
growth inhibition caused by ICG-001
treatment was accompanied by de-
crease in the number of proliferating
(Ki-67þ ) cells and increase in the
number of apoptotic (TUNELþ ) cells
in the hair bulb and the outer root
sheath, compared to the controls (Fig-
ure 2f–i). These data are consistent with
previous report on similar effects of
ICG-001 (inhibition of proliferation and
stimulation of apoptosis) associated
with downregulation of survivin and
increase of caspase-3 activity in several
cell lines (Ma et al., 2005). However,
very limited number of reports is
available on the interactions between
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Figure 2. b-Catenin–survivin interactions in human HF. (a) In anagen HF, survivin immunofluorescence (Rhodamine) was detected in the hair matrix (arrows);
(b) cell membrane staining of b-catenin (FITC) was seen in the upper part of the hair matrix (arrowhead), (c) and nuclear localization of b-catenin in the hair
matrix cells (arrow); colocalization of survivin and b-catenin was detected in hair matrix cells (yellow immunofluorescence, arrows). (d) By ELISA, survivin
protein levels are significantly reduced in the HFs treated with ICG-001, compared to the control. (e) Hair shaft elongation in ICG-001-treated HFs compared to
vehicle control after 4 days in culture. (f–h) Ki-67/TUNEL double staining of HFs after 4 days in culture: (f) numerous Ki-67þ cells are seen in the hair matrix
of the control (arrows);(g and h) treatment with ICG-001 (1–2 mM) decreases the number of Ki-67þ cells (TRITC, arrows), as well as increased number of
TUNELþ cells in the hair bulb and the outer root sheath (arrowheads); (i) total number of Ki-67- and TUNEL-positive cells in the hair matrix of ICG-001- and
vehicle-treated follicles after 4 days in culture.
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survivin and known regulators of apop-
tosis in the HF. Therefore, it would be
very interesting to further explore and/
or identify survivin upstream and down-
stream components in the control of
proliferation and apoptosis in the HF.
In summary, we provide the first
evidence that (1) survivin is expressed
in the proliferating keratinocytes of the
hair matrix and outer root sheath of
human anagen HF and its expression is
decreased with the progression of cata-
gen phase; (2) expression of survivin in
anagen HF may be controlled by Wnt/
b-catenin signaling. The dual functions
of survivin may be involved in the
control of the delicate proliferation–
apoptosis balance controlling HF cyclic
behavior.
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TO THE EDITOR
Genome-wide scanning and linkage
analysis were performed in three Chi-
nese families with disseminated super-
ficial actinic porokeratosis (DSAP) and
the gene was localized to an 8.0-cM
interval defined by D12S330 and
D12S354 on chromosome 12. Mean-
while, both missense mutations,
p.Ser63Asn in slingshot 1 (SSH1)
(Zhang et al., 2004) and a variation
(dbSNP3759383: G4A) in the promo-
Abbreviation: DSAP, disseminated superficial actinic porokeratosis; LOH, loss of heterozygosity;
SSH1, slingshot 1
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